Betapoietin
Betapoietin is the trade name of erythropoietin beta made by CinnaGen and Zahravi, a hormone treatment for anaemia and sometimes used in chemotherapy
Description
Erythropoietin (EPO) is a hormone produced in the kidneys. The existence of this hormone has been known since 1906, when scientists first started isolating it, and since the 1980s, a recombinant version of the hormone known as Epogen or Betapoietin has been available for use in medical treatment. Betapoietin is the recombinant form of human erythropoietin which is produced in rCHO cells. Beatpoietin has the same characteristics of natural human erythropoietin regarding protein sequence. Betapoietin is composed of 165 amino acids with about 30 KDa molecular weight.
Indication
Betapoietin is used for treatment of anemia due to hemodialysis and also for patients under chemotherapy.
Drug form and potency
Betapoietin is available as ready-to-inject liquid vials (syringe) containing 16 micrograms or 2000IU/ml of rhEPO.
Injection
Injection could be intramuscular or subcutaneous.